Literature DB >> 23103628

Castleman's disease in the pelvic retroperitoneum: A case report and review of the Japanese literature.

Atsushi Sato1.   

Abstract

INTRODUCTION: Castleman's disease is a fairly rare benign tumor of lymphoid origin. It can develop anywhere lymphoid tissue is found, but the expected origin is mediastinum and rarely pelvic retroperitoneum. PRESENTATION OF CASE: A 22-year-old woman was admitted to our hospital for a mass in the pelvic retroperitoneum that was detected incidentally on an ultrasonography during a routine medical checkup with no signs of symptoms. After laboratory examination, ultrasonography, and magnetic resonance imaging (MRI), surgical resection was performed successfully through a lower midline incision. But the patient was needed transfusion because of massive bleeding. Postoperative histopathological diagnosis was hyaline-vascular type of Castleman's disease. The patient is leading an active social life without any signs of sequelae or recurrence. DISCUSSION: Through the review of Japanese literature on Castleman's disease in the retroperitoneum, the characteristics of preoperative imaging findings are studied. Castleman's disease is easily misdiagnosed clinically because of its scarcity and no specific imaging findings. And the embolization via angiography should be considered in the hypervasular tumors such as in this case to prevent massive bleeding and transfusion.
CONCLUSION: Although Castleman's disease is uncommon, it should always be included in the differential diagnosis of pelvic retroperitoneal tumors. A better knowledge of this disease would help surgeon to avoid unnecessarily extensive resection and massive bleeding for transfusion when dealing with retroperitoneal tumors.
Copyright © 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2012        PMID: 23103628      PMCID: PMC3537931          DOI: 10.1016/j.ijscr.2012.08.016

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  8 in total

1.  Localized mediastinal lymphnode hyperplasia resembling thymoma.

Authors:  B CASTLEMAN; L IVERSON; V P MENENDEZ
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

2.  A case of incidentally detected Castleman's disease with retroperitoneal paravertebral localization.

Authors:  C Aygun; M I Tekin; B Demirhan; C L Peskircioglu; M Agildere; H Ozkardes
Journal:  Int J Urol       Date:  2000-01       Impact factor: 3.369

3.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

Review 4.  Castleman's disease of the abdomen and pelvis: report of three cases and a review of the literature.

Authors:  H Kiguchi; T Ishii; Y Ishikawa; S Masuda; N Asuwa; K Yamafuji; T Takahashi
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

5.  Surgical management of abdominal and retroperitoneal Castleman's disease.

Authors:  Pascal Bucher; Gilles Chassot; Guillaume Zufferey; Frederic Ris; Olivier Huber; Philippe Morel
Journal:  World J Surg Oncol       Date:  2005-06-07       Impact factor: 2.754

6.  Castleman disease. Unusual retroperitoneal location indistinguishable from malignant tumor in preoperative angiographic appearance.

Authors:  H Takihara; G Yamakawa; Y Baba; M Takahashi; T Ishihara
Journal:  Urology       Date:  1993-02       Impact factor: 2.649

7.  Multicentric giant lymph node hyperplasia. A report of seven cases.

Authors:  E Kessler
Journal:  Cancer       Date:  1985-11-15       Impact factor: 6.860

Review 8.  Retroperitoneal Castleman's disease.

Authors:  J L Seco; F Velasco; J S Manuel; S R Serrano; L Tomas; A Velasco
Journal:  Surgery       Date:  1992-11       Impact factor: 3.982

  8 in total
  1 in total

1.  Isolated retroperitoneal Castleman's disease: A case report and literature review.

Authors:  Jhen-Hao Jhan; Ching-Chia Li; Wen-Jeng Wu; Hsiang-Ying Lee
Journal:  Clin Case Rep       Date:  2018-06-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.